3-METHYL-2 (3-(2-PHENYL-OXAZOL-4-YLMETHOXY)- CYCLOHEXANECARBONYL-AMINO BUTYRIC ACID DERIVATIVES AND RELATED COMPOUNDS AS PPAR MODULATORS FOR THE TREATMENT OF TYPE 2 DIABETES AND ATHEROSCLEROSIS

摘要

The invention relates to cycloalkyl-substituted amino acid derivatives and the physiologically acceptable salts and physiologically functional derivatives thereof. Disclosed are compounds of formula (I), wherein the radicals have the indicated meanings, the physiologically acceptable salts thereof, and methods for the production thereof. The inventive compounds are suitable for treating and/or preventing disturbances of fatty acid metabolism, impaired glucose utilization, and disturbances in which insulin resistance plays a role, for example.